Related Experiment Video
Updated: Aug 23, 2026
Rapid In Situ Hybridization using Oligonucleotide Probes on Paraformaldehyde-prefixed Brain of Rats with Serotonin Syndrome
Published on: September 23, 2015
Increased CRE-binding activity and tryptophan hydroxylase mRNA expression induced by
Ana García-Osta1, Joaquín Del Río, Diana Frechilla
1Department of Pharmacology, University of Navarra, School of Medicine, Aptdo. 177, 31080 Pamplona, Spain.
Abstract:
A single administration of either 3,4-methylenedioxymethamphetamine (MDMA, "ecstasy") or p-chloroamphetamine (PCA) produced a rapid and marked reduction of serotonin (5-HT) content in rat frontal cortex and hippocampus. In the cortex of MDMA-treated rats, 5-HT levels returned to control values 48 h after drug administration. This recovery was correlated with an induction of CRE-binding activity and an enhanced expression of tryptophan hydroxylase (TPH) mRNA, the rate-limiting enzyme in 5-HT biosynthesis, suggesting that MDMA may up-regulate the TPH gene through a CREB-dependent mechanism. In the cortex of PCA-treated rats, neither a recovery of 5-HT levels nor changes in DNA-binding or TPH mRNA were found at the same time point. In the hippocampus of rats receiving either PCA or MDMA a decrease in TPH mRNA levels was found at all times, along with a reduced CRE-binding at the 8-h time point. The results show region-specific effects of MDMA. In the frontal cortex, the increased TPH expression suggests a compensatory response to MDMA-induced loss of serotonergic function.
Insights
3,4-methylenedioxymethamphetamine (MDMA) and p-chloroamphetamine (PCA) reduce serotonin levels in rats. MDMA
Area of Science:
- Neuroscience
- Pharmacology
- Molecular Biology
Background:
- Serotonin (5-HT) is a key neurotransmitter involved in mood and behavior.
- Drugs like MDMA and PCA can significantly impact serotonergic systems.
- Understanding the molecular mechanisms of drug-induced neurotoxicity and recovery is crucial.
Purpose of the Study:
- To investigate the region-specific effects of MDMA and PCA on serotonin levels and related gene expression in the rat brain.
- To elucidate the molecular mechanisms underlying the recovery of serotonergic function after MDMA administration.
Main Methods:
- Administration of MDMA or PCA to rats.
- Measurement of serotonin (5-HT) content in the frontal cortex and hippocampus.
- Analysis of CRE-binding activity.
- Quantification of tryptophan hydroxylase (TPH) mRNA expression.
Main Results:
- Both MDMA and PCA caused a rapid and significant reduction in 5-HT content in the frontal cortex and hippocampus.
- In the frontal cortex, 5-HT levels recovered within 48 hours after MDMA administration.
- MDMA treatment led to increased CRE-binding activity and TPH mRNA expression in the frontal cortex, suggesting TPH gene up-regulation.
- PCA treatment did not result in 5-HT recovery or changes in TPH mRNA in the cortex.
- Both drugs decreased TPH mRNA levels and CRE-binding activity in the hippocampus.
Conclusions:
- MDMA exhibits region-specific effects on the serotonergic system.
- The frontal cortex shows a compensatory response to MDMA-induced 5-HT depletion, involving TPH gene up-regulation via a CREB-dependent mechanism.
- PCA does not induce similar recovery mechanisms in the frontal cortex.
- Hippocampal serotonergic function is impaired by both MDMA and PCA, with decreased TPH mRNA expression.
